0.598
前日終値:
$0.572
開ける:
$0.5806
24時間の取引高:
4.47M
Relative Volume:
0.87
時価総額:
$180.42M
収益:
$52.29M
当期純損益:
$-134.84M
株価収益率:
-0.7973
EPS:
-0.75
ネットキャッシュフロー:
$-117.11M
1週間 パフォーマンス:
-5.57%
1か月 パフォーマンス:
-11.20%
6か月 パフォーマンス:
-22.55%
1年 パフォーマンス:
-64.82%
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
名前
Sangamo Therapeutics Inc
セクター
電話
(510) 970-6000
住所
501 CANAL BLVD., RICHMOND, CA
SGMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SGMO
Sangamo Therapeutics Inc
|
0.598 | 172.58M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-13 | アップグレード | Truist | Hold → Buy |
| 2024-12-10 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-11-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-02-27 | アップグレード | Wedbush | Neutral → Outperform |
| 2023-01-06 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-06-13 | 再開されました | Wedbush | Neutral |
| 2021-05-04 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-01-07 | 再開されました | Guggenheim | Neutral |
| 2021-01-06 | 開始されました | Stifel | Hold |
| 2020-12-16 | 再開されました | H.C. Wainwright | Buy |
| 2020-09-08 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | SunTrust | Buy |
| 2019-08-26 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-11-09 | ダウングレード | Guggenheim | Buy → Neutral |
| 2018-10-10 | 開始されました | Guggenheim | Buy |
| 2018-06-20 | 開始されました | BofA/Merrill | Buy |
| 2017-11-15 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | 再開されました | Jefferies | Buy |
| 2016-11-01 | ダウングレード | Wedbush | Outperform → Neutral |
| 2016-10-19 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | 開始されました | Wells Fargo | Outperform |
| 2015-10-23 | 再開されました | Jefferies | Buy |
| 2013-05-03 | 開始されました | BioLogic Equity Research | Sell |
| 2011-02-23 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2010-07-29 | 繰り返されました | Wedbush | Outperform |
| 2009-10-19 | 開始されました | Brean Murray | Sell |
| 2009-10-07 | 繰り返されました | Leerink Swann | Outperform |
| 2009-08-25 | 繰り返されました | JMP Securities | Mkt Outperform |
すべてを表示
Sangamo Therapeutics Inc (SGMO) 最新ニュース
Is Sangamo Therapeutics Inc. stock a safe haven assetEntry Point & High Conviction Buy Zone Picks - newser.com
Will Sangamo Therapeutics Inc. stock outperform Nasdaq indexWeekly Trend Report & Low Drawdown Momentum Ideas - newser.com
Using AI based signals to follow Sangamo Therapeutics Inc.Market Trend Review & Safe Capital Preservation Plans - newser.com
Detecting price anomalies in Sangamo Therapeutics Inc. with AIJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
Sangamo Therapeutics Inc. stock chart pattern explainedMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
How Sangamo Therapeutics Inc. stock reacts to bond yieldsWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Real time pattern detection on Sangamo Therapeutics Inc. stockEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
Is Sangamo Therapeutics Inc. stock in correction or buying zoneMarket Growth Report & Smart Allocation Stock Tips - newser.com
Published on: 2025-10-31 05:14:43 - newser.com
How hedge fund analytics apply to Sangamo Therapeutics Inc. stock2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Why retail investors favor Sangamo Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
What machine learning models say about Sangamo Therapeutics Inc.Quarterly Growth Report & Expert Curated Trade Setups - newser.com
What analyst consensus says on Sangamo Therapeutics Inc. stockTrade Risk Report & Fast Exit/Entry Strategy Plans - newser.com
What analysts say about Sangamo Therapeutics Inc stockEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call - The Manila Times
We're Hopeful That Sangamo Therapeutics (NASDAQ:SGMO) Will Use Its Cash Wisely - Yahoo Finance
Published on: 2025-10-29 21:25:18 - newser.com
Sangamo Biosciences Granted Nasdaq Compliance Extension - TipRanks
Published on: 2025-10-27 19:21:18 - newser.com
Will Sangamo Therapeutics Inc. stock gain from strong economyRate Cut & Free Real-Time Market Sentiment Alerts - Fundação Cultural do Pará
Market Recap: How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingWeekly Trade Summary & Real-Time Stock Price Movement Reports - Fundação Cultural do Pará
Published on: 2025-10-27 08:50:01 - newser.com
Published on: 2025-10-27 07:49:20 - newser.com
Sangamo Therapeutics Inc (SGMO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):